Higher Uveitis Risk in Cancer Patients on BRAF Inhibitors

BRAF inhibitors raise the risk for uveitis in patients with skin melanoma or lung cancer compared with conventional cytotoxic drugs or immune checkpoint inhibitors.
Medscape Medical News

source https://www.medscape.com/viewarticle/higher-uveitis-risk-patients-cancer-braf-inhibitors-2024a1000ekr?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost